[go: up one dir, main page]

PL1682091T3 - Kompozycje lipidów i kationowych peptydów - Google Patents

Kompozycje lipidów i kationowych peptydów

Info

Publication number
PL1682091T3
PL1682091T3 PL04798419T PL04798419T PL1682091T3 PL 1682091 T3 PL1682091 T3 PL 1682091T3 PL 04798419 T PL04798419 T PL 04798419T PL 04798419 T PL04798419 T PL 04798419T PL 1682091 T3 PL1682091 T3 PL 1682091T3
Authority
PL
Poland
Prior art keywords
lipids
compositions
cationic peptides
peptides
cationic
Prior art date
Application number
PL04798419T
Other languages
English (en)
Inventor
Fredrik Joabsson
Fredrik Tiberg
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0326074A external-priority patent/GB0326074D0/en
Priority claimed from GB0326075A external-priority patent/GB0326075D0/en
Priority claimed from GB0412544A external-priority patent/GB0412544D0/en
Application filed by Camurus Ab filed Critical Camurus Ab
Publication of PL1682091T3 publication Critical patent/PL1682091T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL04798419T 2003-11-07 2004-11-05 Kompozycje lipidów i kationowych peptydów PL1682091T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0326074A GB0326074D0 (en) 2003-11-07 2003-11-07 Method
GB0326075A GB0326075D0 (en) 2003-11-07 2003-11-07 Compositions
GB0412544A GB0412544D0 (en) 2004-06-04 2004-06-04 Compositions

Publications (1)

Publication Number Publication Date
PL1682091T3 true PL1682091T3 (pl) 2017-09-29

Family

ID=34595630

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04798419T PL1682091T3 (pl) 2003-11-07 2004-11-05 Kompozycje lipidów i kationowych peptydów

Country Status (7)

Country Link
US (1) US8865021B2 (pl)
EP (1) EP1682091B1 (pl)
JP (1) JP5600233B2 (pl)
DK (1) DK1682091T3 (pl)
ES (1) ES2623881T3 (pl)
PL (1) PL1682091T3 (pl)
WO (1) WO2005046642A1 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG173326A1 (en) 2004-06-04 2011-08-29 Camurus Ab Liquid depot formulations
DE602005026998D1 (de) * 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
EP1848403B8 (en) * 2005-01-14 2010-05-19 Camurus Ab Topical bioadhesive formulations
ES2343641T3 (es) * 2005-01-14 2010-08-05 Camurus Ab Formulaciones bioadhesivas topicas.
KR100983746B1 (ko) * 2005-01-14 2010-09-24 카무러스 에이비 소마토스타틴 유사 제형
US9060935B2 (en) 2005-01-21 2015-06-23 Camurus Ab Pharmaceutical lipid compositions
ES2399645T3 (es) 2005-06-06 2013-04-02 Camurus Ab Formulaciones de análogos de GLP-1
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
EP2044934A1 (en) * 2007-10-01 2009-04-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
EP2886105B1 (en) * 2007-10-24 2018-12-05 Camurus Ab Controlled-release formulations
ATE513027T1 (de) * 2008-04-02 2011-07-15 Nestec Sa Funktionelle mesophasen auf oleylethanolamidbasis
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
HRP20170929T1 (hr) 2008-09-17 2017-09-22 Chiasma Inc. Farmaceutski pripravci i odgovarajući postupci za isporuku
WO2010150262A2 (en) * 2009-06-25 2010-12-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Reverse hexagonal mesophases (hii) and uses thereof
KR102066755B1 (ko) * 2011-05-25 2020-01-15 카무러스 에이비 조절 방출형 펩티드 제형
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
AU2012348640B2 (en) * 2011-12-05 2016-07-21 Camurus Ab Robust controlled-release peptide formulations
IN2014DN09831A (pl) 2012-05-25 2015-08-07 Camurus Ab
PL2877155T3 (pl) 2012-07-26 2021-05-17 Camurus Ab Formulacje opioidowe
LT2877155T (lt) 2012-07-26 2021-02-25 Camurus Ab Opioidų vaisto formos
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586789B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
AU2015360485B2 (en) 2014-12-10 2020-06-25 Amryt Endo, Inc. Oral octreotide administered in combination with other therapeutic agents
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
WO2017100580A1 (en) * 2015-12-10 2017-06-15 Aaron Seitz Sphingolipid coatings and process for manufacturing sphingolipid coatings effective for inhibiting biofilm formation
KR102186704B1 (ko) * 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
JP7542661B2 (ja) * 2020-06-30 2024-08-30 チョン クン ダン ファーマシューティカル コーポレーション Ｇｎｒｈ誘導体を含む注射用組成物
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
MX2024002306A (es) * 2021-08-23 2024-03-07 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Nanosistemas cristalinos liquidos liotropicos con macromoleculas bioactivas encapsuladas.
GR1010458B (el) * 2022-07-21 2023-05-15 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Νανοσυστηματα βιοδραστικων μακρομοριων με πεπτιδικους δεσμους σε μορφη νανοδομημενων λυοτροπικων υγρων κρυσταλλων
GR1010501B (el) * 2022-06-08 2023-07-07 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Νανοσυστηματα βιοδραστικων μακρομοριων σε μορφη νανοδομημενων λυοτροπικων υγρων κρυσταλλων
GR1010363B (el) * 2021-08-23 2022-12-21 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Νανοσωματιδια λυοτροπικων λιπιδικων υγρων κρυσταλλων για χρηση ως συστηματα μεταφορας δραστικων φαρμακευτικων ουσιων

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2699892A (en) 1991-10-04 1993-05-03 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
SE518578C2 (sv) 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
JP2003520049A (ja) * 2000-01-18 2003-07-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ヒトタンパク質であるチロシンホスファターゼのポリヌクレオチド、ポリペプチド、および抗体
GB0305941D0 (en) 2003-03-14 2003-04-23 Camurus Ab Composition

Also Published As

Publication number Publication date
JP5600233B2 (ja) 2014-10-01
EP1682091A1 (en) 2006-07-26
EP1682091B1 (en) 2017-03-29
DK1682091T3 (en) 2017-05-15
US20070080323A1 (en) 2007-04-12
ES2623881T3 (es) 2017-07-12
WO2005046642A1 (en) 2005-05-26
US8865021B2 (en) 2014-10-21
JP2007510705A (ja) 2007-04-26

Similar Documents

Publication Publication Date Title
PL1682091T3 (pl) Kompozycje lipidów i kationowych peptydów
PL377614A1 (pl) Kompozycje zawierające kwasy tłuszczowe i aminokwasy
EP1606315A4 (en) COMPOSITIONS AND THEIR USES COMPATIBLE TO ANY PRESENTING COMPLEX BINDING
PL2204168T3 (pl) Preparaty tetracyklin do jedorazowego dziennego podawania
EP1632213A4 (en) COSMETIC PREPARATION
IL197889A (en) Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
IL173440A0 (en) Novel formulation of ropinirole
IL176384A (en) Pyrrolidinochlorinated basazole and pharmacy preparations containing them
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
GB0214805D0 (en) Cosmetic compositions
EP1620089A4 (en) Therapeutic and prophylactic compositions and their uses
AU2003249114A8 (en) Cosmetic composition
ZA200410163B (en) Improved distribution and preparation of germicidal compositions
GB2384705B (en) Cosmetic and related compositions
TWI350750B (en) Compositions comprising cyclohexylamines and aminoadamantanes
PL378052A1 (pl) Kationowe peptydy przeciwdrobnoustrojowe i sposoby ich zastosowania
GB0309064D0 (en) Modified peptides and their uses
GB0310259D0 (en) Cosmetic compositions
PL371788A1 (pl) Kompozycje farmaceutyczne i kosmetyczne zawierające PLGF-1
AU2003228896A8 (en) Anti-microbial peptides and compositions
EP1608970A4 (en) CCN3 COMPOSITIONS AND METHODS
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
AU2003901205A0 (en) Therapeutic and prophylactic compositions and uses therefor
GB0327050D0 (en) Therapeutic methods compositions and uses
GB0325942D0 (en) Compositions and uses thereof